Facile synthesis of 14C-nitrofurazone from 14C-urea

IF 0.9 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS
Anuradha Singh, David J. Smith
{"title":"Facile synthesis of 14C-nitrofurazone from 14C-urea","authors":"Anuradha Singh,&nbsp;David J. Smith","doi":"10.1002/jlcr.4068","DOIUrl":null,"url":null,"abstract":"<p>The veterinary drug nitrofurazone (5-nitro-2-furaldehyde semicarbazone) exhibits excellent antimicrobial properties but its application in food-producing animals is prohibited. The illegal use of nitrofurazone is regularly monitored by food regulatory agencies. Currently, semicarbazide (SEM) is used as a marker of nitrofurazone exposure. However, the use of SEM as a marker of nitrofurazone is under scrutiny after evidence of a high incidence of false positive tests. To overcome the current dilemma, it is necessary to identify a nitrofurazone-specific marker analyte which requires conducting nitrofurazone metabolism studies in food-producing animals. The use of carbon-14 labeled nitrofurazone would facilitate metabolism studies and structural elucidation of nitrofurazone metabolites of possible utility as a marker compound. In the present work, a synthetic method is described to procure radiolabeled nitrofurazone that incorporates <sup>14</sup>C- carbon at the semicarbazide moiety. The method incorporates <sup>14</sup>C-carbon via employing readily available and more economically affordable [<sup>14</sup>C]-urea compared with [<sup>14</sup>C]-semicarbazide. To the best of our knowledge, there is no report on the synthesis of 5-nitro-2-furaldehyde [<sup>14</sup>C]-semicarbazone from <sup>14</sup>C-urea. The developed method involves monoamination of [<sup>14</sup>C]-urea followed by a condensation reaction with 5-nitro-2-furaldehyde to produce 5-nitro-2-furaldehyde [<sup>14</sup>C]-semicarbazone in 85% yield with greater than 98% radiochemical purity.</p>","PeriodicalId":16288,"journal":{"name":"Journal of labelled compounds & radiopharmaceuticals","volume":"66 14","pages":"467-472"},"PeriodicalIF":0.9000,"publicationDate":"2023-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of labelled compounds & radiopharmaceuticals","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jlcr.4068","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

Abstract

The veterinary drug nitrofurazone (5-nitro-2-furaldehyde semicarbazone) exhibits excellent antimicrobial properties but its application in food-producing animals is prohibited. The illegal use of nitrofurazone is regularly monitored by food regulatory agencies. Currently, semicarbazide (SEM) is used as a marker of nitrofurazone exposure. However, the use of SEM as a marker of nitrofurazone is under scrutiny after evidence of a high incidence of false positive tests. To overcome the current dilemma, it is necessary to identify a nitrofurazone-specific marker analyte which requires conducting nitrofurazone metabolism studies in food-producing animals. The use of carbon-14 labeled nitrofurazone would facilitate metabolism studies and structural elucidation of nitrofurazone metabolites of possible utility as a marker compound. In the present work, a synthetic method is described to procure radiolabeled nitrofurazone that incorporates 14C- carbon at the semicarbazide moiety. The method incorporates 14C-carbon via employing readily available and more economically affordable [14C]-urea compared with [14C]-semicarbazide. To the best of our knowledge, there is no report on the synthesis of 5-nitro-2-furaldehyde [14C]-semicarbazone from 14C-urea. The developed method involves monoamination of [14C]-urea followed by a condensation reaction with 5-nitro-2-furaldehyde to produce 5-nitro-2-furaldehyde [14C]-semicarbazone in 85% yield with greater than 98% radiochemical purity.

Abstract Image

用14C-尿素催化合成14C-硝基呋喃酮。
兽药呋喃西林(5-硝基-2-呋喃甲醛缩氨基脲)具有良好的抗菌性能,但禁止在食品生产动物中使用。食品监管机构定期监测呋喃西林的非法使用情况。目前,氨基脲(SEM)被用作接触呋喃西林的标志。然而,在有证据表明假阳性检测的发生率很高后,扫描电镜作为呋喃西林标志物的使用受到了仔细审查。为了克服目前的困境,有必要鉴定呋喃西林特异性标记物分析物,这需要在食品生产动物中进行呋喃西林代谢研究。碳-14标记的呋喃西林的使用将促进代谢研究和呋喃西林代谢产物的结构阐明,这些代谢产物可能用作标记化合物。在本工作中,描述了一种合成方法来获得放射性标记的硝基呋喃酮,该硝基呋喃酮在氨基脲部分结合了14C-碳。与[14 C]-氨基脲相比,该方法通过使用易于获得且经济实惠的[14 C]-脲来结合14 C-碳。据我们所知,目前还没有关于由14C-尿素合成5-硝基-2-糠醛[14C]-氨基脲的报道。所开发的方法包括[14C]-尿素的单胺化,然后与5-硝基-2-糠醛缩合反应,以85%的产率生产5-硝基-2-呋喃甲醛[14C]-氨基脲,放射化学纯度大于98%。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.30
自引率
0.00%
发文量
57
审稿时长
1 months
期刊介绍: The Journal of Labelled Compounds and Radiopharmaceuticals publishes all aspects of research dealing with labeled compound preparation and applications of these compounds. This includes tracer methods used in medical, pharmacological, biological, biochemical and chemical research in vitro and in vivo. The Journal of Labelled Compounds and Radiopharmaceuticals devotes particular attention to biomedical research, diagnostic and therapeutic applications of radiopharmaceuticals, covering all stages of development from basic metabolic research and technological development to preclinical and clinical studies based on physically and chemically well characterized molecular structures, coordination compounds and nano-particles.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信